A retrospective study for safety and efficacy of apatinib combined with concurrent chemoradiotherapy in the treatment of non-operative oesophageal cancer
Latest Information Update: 09 Oct 2020
At a glance
- Drugs Rivoceranib (Primary) ; Antineoplastics
- Indications Oesophageal cancer
- Focus Adverse reactions; Therapeutic Use
- 09 Oct 2020 New trial record
- 21 Sep 2020 Results presented at the 45th European Society for Medical Oncology Congress